Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice

Most cells acquire cholesterol by endocytosis of circulating low-density lipoproteins (LDLs). After cholesteryl ester de-esterification in endosomes, free cholesterol is redistributed to intracellular membranes via unclear mechanisms. Our previous work suggested that the unconventional phospholipid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO reports 2019-07, Vol.20 (7), p.e47055
Hauptverfasser: Moreau, Dimitri, Vacca, Fabrizio, Vossio, Stefania, Scott, Cameron, Colaco, Alexandria, Paz Montoya, Jonathan, Ferguson, Charles, Damme, Markus, Moniatte, Marc, Parton, Robert G, Platt, Frances M, Gruenberg, Jean
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page e47055
container_title EMBO reports
container_volume 20
creator Moreau, Dimitri
Vacca, Fabrizio
Vossio, Stefania
Scott, Cameron
Colaco, Alexandria
Paz Montoya, Jonathan
Ferguson, Charles
Damme, Markus
Moniatte, Marc
Parton, Robert G
Platt, Frances M
Gruenberg, Jean
description Most cells acquire cholesterol by endocytosis of circulating low-density lipoproteins (LDLs). After cholesteryl ester de-esterification in endosomes, free cholesterol is redistributed to intracellular membranes via unclear mechanisms. Our previous work suggested that the unconventional phospholipid lysobisphosphatidic acid (LBPA) may play a role in modulating the cholesterol flux through endosomes. In this study, we used the Prestwick library of FDA-approved compounds in a high-content, image-based screen of the endosomal lipids, lysobisphosphatidic acid and LDL-derived cholesterol. We report that thioperamide maleate, an inverse agonist of the histamine H3 receptor HRH3, increases highly selectively the levels of lysobisphosphatidic acid, without affecting any endosomal protein or function that we tested. Our data also show that thioperamide significantly reduces the endosome cholesterol overload in fibroblasts from patients with the cholesterol storage disorder Niemann-Pick type C (NPC), as well as in liver of Npc1 mice. We conclude that LBPA controls endosomal cholesterol mobilization and export to cellular destinations, perhaps by fluidifying or buffering cholesterol in endosomal membranes, and that thioperamide has repurposing potential for the treatment of NPC.
doi_str_mv 10.15252/embr.201847055
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6607015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31267706</sourcerecordid><originalsourceid>FETCH-LOGICAL-p163t-377ac8ca360e8955024c8362fb88b8b3475aa05023212aba494d93afe8aa37173</originalsourceid><addsrcrecordid>eNpVkElLA0EQhRtRjEbP3qT_wMReppe5CBJXCOpBwdtQ01NJWmejexLMv3eCUfRQvMd7Vd-hCDnjbMKVUOIC6yJMBOM2NUypPXLEU50lkhu7v_NC8LcROY7xnTGmMmMPyUhyoY1h-oh8XofVIvFNuXJYUt-4gBBxMLTaxLbwsVu2w0DvS-8oOF_SgNvlSPslUrdsK4w9hrai7RpD1cKWQh891tA0ybN3H7TfdEin1GFVRQpNSWvv8IQczKGKeLrTMXm9vXmZ3iezp7uH6dUs6biWfSKNAWcdSM3QZkoxkTortZgX1ha2kKlRAGyIpeACCkiztMwkzNECSMONHJPLb263KmosHTZ9gCrvgq8hbPIWfP6_afwyX7TrXGtmGFcD4Pwv4Pfy54fyC6Scdyc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Wiley Free Content</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><creator>Moreau, Dimitri ; Vacca, Fabrizio ; Vossio, Stefania ; Scott, Cameron ; Colaco, Alexandria ; Paz Montoya, Jonathan ; Ferguson, Charles ; Damme, Markus ; Moniatte, Marc ; Parton, Robert G ; Platt, Frances M ; Gruenberg, Jean</creator><creatorcontrib>Moreau, Dimitri ; Vacca, Fabrizio ; Vossio, Stefania ; Scott, Cameron ; Colaco, Alexandria ; Paz Montoya, Jonathan ; Ferguson, Charles ; Damme, Markus ; Moniatte, Marc ; Parton, Robert G ; Platt, Frances M ; Gruenberg, Jean</creatorcontrib><description>Most cells acquire cholesterol by endocytosis of circulating low-density lipoproteins (LDLs). After cholesteryl ester de-esterification in endosomes, free cholesterol is redistributed to intracellular membranes via unclear mechanisms. Our previous work suggested that the unconventional phospholipid lysobisphosphatidic acid (LBPA) may play a role in modulating the cholesterol flux through endosomes. In this study, we used the Prestwick library of FDA-approved compounds in a high-content, image-based screen of the endosomal lipids, lysobisphosphatidic acid and LDL-derived cholesterol. We report that thioperamide maleate, an inverse agonist of the histamine H3 receptor HRH3, increases highly selectively the levels of lysobisphosphatidic acid, without affecting any endosomal protein or function that we tested. Our data also show that thioperamide significantly reduces the endosome cholesterol overload in fibroblasts from patients with the cholesterol storage disorder Niemann-Pick type C (NPC), as well as in liver of Npc1 mice. We conclude that LBPA controls endosomal cholesterol mobilization and export to cellular destinations, perhaps by fluidifying or buffering cholesterol in endosomal membranes, and that thioperamide has repurposing potential for the treatment of NPC.</description><identifier>ISSN: 1469-221X</identifier><identifier>EISSN: 1469-3178</identifier><identifier>DOI: 10.15252/embr.201847055</identifier><identifier>PMID: 31267706</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Animals ; Cells, Cultured ; Cholesterol - metabolism ; Endosomes - drug effects ; Endosomes - metabolism ; Female ; Fibroblasts - drug effects ; Fibroblasts - metabolism ; HeLa Cells ; Humans ; Lysophospholipids - metabolism ; Male ; Mice ; Mice, Inbred BALB C ; Monoglycerides - metabolism ; Niemann-Pick Disease, Type C - metabolism ; Piperidines - pharmacology</subject><ispartof>EMBO reports, 2019-07, Vol.20 (7), p.e47055</ispartof><rights>2019 The Authors. Published under the terms of the CC BY 4.0 license.</rights><rights>2019 The Authors. Published under the terms of the CC BY 4.0 license</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-7494-5248 ; 0000-0003-3984-1395 ; 0000-0002-0300-4862</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607015/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607015/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,887,27931,27932,53798,53800</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31267706$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moreau, Dimitri</creatorcontrib><creatorcontrib>Vacca, Fabrizio</creatorcontrib><creatorcontrib>Vossio, Stefania</creatorcontrib><creatorcontrib>Scott, Cameron</creatorcontrib><creatorcontrib>Colaco, Alexandria</creatorcontrib><creatorcontrib>Paz Montoya, Jonathan</creatorcontrib><creatorcontrib>Ferguson, Charles</creatorcontrib><creatorcontrib>Damme, Markus</creatorcontrib><creatorcontrib>Moniatte, Marc</creatorcontrib><creatorcontrib>Parton, Robert G</creatorcontrib><creatorcontrib>Platt, Frances M</creatorcontrib><creatorcontrib>Gruenberg, Jean</creatorcontrib><title>Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice</title><title>EMBO reports</title><addtitle>EMBO Rep</addtitle><description>Most cells acquire cholesterol by endocytosis of circulating low-density lipoproteins (LDLs). After cholesteryl ester de-esterification in endosomes, free cholesterol is redistributed to intracellular membranes via unclear mechanisms. Our previous work suggested that the unconventional phospholipid lysobisphosphatidic acid (LBPA) may play a role in modulating the cholesterol flux through endosomes. In this study, we used the Prestwick library of FDA-approved compounds in a high-content, image-based screen of the endosomal lipids, lysobisphosphatidic acid and LDL-derived cholesterol. We report that thioperamide maleate, an inverse agonist of the histamine H3 receptor HRH3, increases highly selectively the levels of lysobisphosphatidic acid, without affecting any endosomal protein or function that we tested. Our data also show that thioperamide significantly reduces the endosome cholesterol overload in fibroblasts from patients with the cholesterol storage disorder Niemann-Pick type C (NPC), as well as in liver of Npc1 mice. We conclude that LBPA controls endosomal cholesterol mobilization and export to cellular destinations, perhaps by fluidifying or buffering cholesterol in endosomal membranes, and that thioperamide has repurposing potential for the treatment of NPC.</description><subject>Animals</subject><subject>Cells, Cultured</subject><subject>Cholesterol - metabolism</subject><subject>Endosomes - drug effects</subject><subject>Endosomes - metabolism</subject><subject>Female</subject><subject>Fibroblasts - drug effects</subject><subject>Fibroblasts - metabolism</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Lysophospholipids - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Monoglycerides - metabolism</subject><subject>Niemann-Pick Disease, Type C - metabolism</subject><subject>Piperidines - pharmacology</subject><issn>1469-221X</issn><issn>1469-3178</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkElLA0EQhRtRjEbP3qT_wMReppe5CBJXCOpBwdtQ01NJWmejexLMv3eCUfRQvMd7Vd-hCDnjbMKVUOIC6yJMBOM2NUypPXLEU50lkhu7v_NC8LcROY7xnTGmMmMPyUhyoY1h-oh8XofVIvFNuXJYUt-4gBBxMLTaxLbwsVu2w0DvS-8oOF_SgNvlSPslUrdsK4w9hrai7RpD1cKWQh891tA0ybN3H7TfdEin1GFVRQpNSWvv8IQczKGKeLrTMXm9vXmZ3iezp7uH6dUs6biWfSKNAWcdSM3QZkoxkTortZgX1ha2kKlRAGyIpeACCkiztMwkzNECSMONHJPLb263KmosHTZ9gCrvgq8hbPIWfP6_afwyX7TrXGtmGFcD4Pwv4Pfy54fyC6Scdyc</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Moreau, Dimitri</creator><creator>Vacca, Fabrizio</creator><creator>Vossio, Stefania</creator><creator>Scott, Cameron</creator><creator>Colaco, Alexandria</creator><creator>Paz Montoya, Jonathan</creator><creator>Ferguson, Charles</creator><creator>Damme, Markus</creator><creator>Moniatte, Marc</creator><creator>Parton, Robert G</creator><creator>Platt, Frances M</creator><creator>Gruenberg, Jean</creator><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7494-5248</orcidid><orcidid>https://orcid.org/0000-0003-3984-1395</orcidid><orcidid>https://orcid.org/0000-0002-0300-4862</orcidid></search><sort><creationdate>20190701</creationdate><title>Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice</title><author>Moreau, Dimitri ; Vacca, Fabrizio ; Vossio, Stefania ; Scott, Cameron ; Colaco, Alexandria ; Paz Montoya, Jonathan ; Ferguson, Charles ; Damme, Markus ; Moniatte, Marc ; Parton, Robert G ; Platt, Frances M ; Gruenberg, Jean</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p163t-377ac8ca360e8955024c8362fb88b8b3475aa05023212aba494d93afe8aa37173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Cells, Cultured</topic><topic>Cholesterol - metabolism</topic><topic>Endosomes - drug effects</topic><topic>Endosomes - metabolism</topic><topic>Female</topic><topic>Fibroblasts - drug effects</topic><topic>Fibroblasts - metabolism</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Lysophospholipids - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Monoglycerides - metabolism</topic><topic>Niemann-Pick Disease, Type C - metabolism</topic><topic>Piperidines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moreau, Dimitri</creatorcontrib><creatorcontrib>Vacca, Fabrizio</creatorcontrib><creatorcontrib>Vossio, Stefania</creatorcontrib><creatorcontrib>Scott, Cameron</creatorcontrib><creatorcontrib>Colaco, Alexandria</creatorcontrib><creatorcontrib>Paz Montoya, Jonathan</creatorcontrib><creatorcontrib>Ferguson, Charles</creatorcontrib><creatorcontrib>Damme, Markus</creatorcontrib><creatorcontrib>Moniatte, Marc</creatorcontrib><creatorcontrib>Parton, Robert G</creatorcontrib><creatorcontrib>Platt, Frances M</creatorcontrib><creatorcontrib>Gruenberg, Jean</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EMBO reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moreau, Dimitri</au><au>Vacca, Fabrizio</au><au>Vossio, Stefania</au><au>Scott, Cameron</au><au>Colaco, Alexandria</au><au>Paz Montoya, Jonathan</au><au>Ferguson, Charles</au><au>Damme, Markus</au><au>Moniatte, Marc</au><au>Parton, Robert G</au><au>Platt, Frances M</au><au>Gruenberg, Jean</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice</atitle><jtitle>EMBO reports</jtitle><addtitle>EMBO Rep</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>20</volume><issue>7</issue><spage>e47055</spage><pages>e47055-</pages><issn>1469-221X</issn><eissn>1469-3178</eissn><abstract>Most cells acquire cholesterol by endocytosis of circulating low-density lipoproteins (LDLs). After cholesteryl ester de-esterification in endosomes, free cholesterol is redistributed to intracellular membranes via unclear mechanisms. Our previous work suggested that the unconventional phospholipid lysobisphosphatidic acid (LBPA) may play a role in modulating the cholesterol flux through endosomes. In this study, we used the Prestwick library of FDA-approved compounds in a high-content, image-based screen of the endosomal lipids, lysobisphosphatidic acid and LDL-derived cholesterol. We report that thioperamide maleate, an inverse agonist of the histamine H3 receptor HRH3, increases highly selectively the levels of lysobisphosphatidic acid, without affecting any endosomal protein or function that we tested. Our data also show that thioperamide significantly reduces the endosome cholesterol overload in fibroblasts from patients with the cholesterol storage disorder Niemann-Pick type C (NPC), as well as in liver of Npc1 mice. We conclude that LBPA controls endosomal cholesterol mobilization and export to cellular destinations, perhaps by fluidifying or buffering cholesterol in endosomal membranes, and that thioperamide has repurposing potential for the treatment of NPC.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>31267706</pmid><doi>10.15252/embr.201847055</doi><orcidid>https://orcid.org/0000-0002-7494-5248</orcidid><orcidid>https://orcid.org/0000-0003-3984-1395</orcidid><orcidid>https://orcid.org/0000-0002-0300-4862</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1469-221X
ispartof EMBO reports, 2019-07, Vol.20 (7), p.e47055
issn 1469-221X
1469-3178
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6607015
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Wiley Free Content; PubMed Central; Springer Nature OA/Free Journals
subjects Animals
Cells, Cultured
Cholesterol - metabolism
Endosomes - drug effects
Endosomes - metabolism
Female
Fibroblasts - drug effects
Fibroblasts - metabolism
HeLa Cells
Humans
Lysophospholipids - metabolism
Male
Mice
Mice, Inbred BALB C
Monoglycerides - metabolism
Niemann-Pick Disease, Type C - metabolism
Piperidines - pharmacology
title Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T03%3A47%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-induced%20increase%20in%20lysobisphosphatidic%20acid%20reduces%20the%20cholesterol%20overload%20in%20Niemann-Pick%20type%20C%20cells%20and%20mice&rft.jtitle=EMBO%20reports&rft.au=Moreau,%20Dimitri&rft.date=2019-07-01&rft.volume=20&rft.issue=7&rft.spage=e47055&rft.pages=e47055-&rft.issn=1469-221X&rft.eissn=1469-3178&rft_id=info:doi/10.15252/embr.201847055&rft_dat=%3Cpubmed%3E31267706%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31267706&rfr_iscdi=true